IMCR

NASDAQStock

Immunocore Holdings plc

$31.22-1.30 (-4.00%)

52-Week Range

$24.53
$40.22

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Volume

156.5K

Avg Volume

397.6K

Performance

1M

-5.42%

3M

-15.65%

6M

-9.82%

YTD

-8.11%

1Y

+6.85%

3Y

-40.67%

5Y

-15.97%

Price Chart

ETF Exposure

IMCR is held by 15 ETFs

ETFFund NameWeight
GERMETFMG Treatments, Testing and Advancements ETF3.67%
BBPVirtus Biotech ETF1.38%
SBIOALPS Medical Breakthroughs ETF1.08%
CANCTema Oncology ETF0.59%
FTKIFirst Trust Small Cap BuyWrite Income ETF0.20%
GWXState Street SPDR S&P International Small Cap ETF0.13%
IBBiShares Biotechnology ETF0.11%
IBBQInvesco Nasdaq Biotechnology ETF0.11%
TNXTT. Rowe Price Innovation Leaders ETF0.09%
ISCFiShares International Small-Cap Equity Factor ETF0.09%
BIBProShares - Ultra Nasdaq Biotechnology0.07%
VALTETFMG Sit Ultra Short ETF0.02%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
SPDWState Street SPDR Portfolio Developed World ex-US ETF0.01%

About IMCR ETF Exposure

Immunocore Holdings plc (IMCR) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $31.22. Investors can gain exposure to IMCR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMCR, sorted by portfolio weight.